Chang MY - Search Results

1

Mechanism-based therapeutics for autosomal dominant polycystic kidney disease: recent progress and future prospects.

Chang MY, Ong AC. Chang MY, et al. Nephron Clin Pract. 2012;120(1):c25-34; discussion c35. doi: 10.1159/000334166. Epub 2011 Dec 23. Nephron Clin Pract. 2012. PMID: 22205396 Review.

2

Mutations of the PKD2 gene in Taiwanese patients with autosomal dominant polycystic kidney disease.

Chang MY, Fang JT, Huang CC, Wu IW, Wu Chou YH. Chang MY, et al. Ren Fail. 2005;27(1):95-100. Ren Fail. 2005. PMID: 15717641

3

Endothelin B receptor blockade accelerates disease progression in a murine model of autosomal dominant polycystic kidney disease.

Chang MY, Parker E, El Nahas M, Haylor JL, Ong AC. Chang MY, et al. J Am Soc Nephrol. 2007 Feb;18(2):560-9. doi: 10.1681/ASN.2006090994. Epub 2007 Jan 3. J Am Soc Nephrol. 2007. PMID: 17202412

4

Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and treatment.

Chang MY, Ong AC. Chang MY, et al. Nephron Physiol. 2008;108(1):p1-7. doi: 10.1159/000112495. Epub 2007 Dec 13. Nephron Physiol. 2008. PMID: 18075279 Review.

5

Concurrent renal cell carcinoma and central nervous system lymphoma in a patient with autosomal dominant polycystic kidney disease.

Chang MY, Chen YM, Chen YC, Tian YC, Fang JT, Yang CW. Chang MY, et al. Med Princ Pract. 2009;18(6):486-9. doi: 10.1159/000235900. Epub 2009 Sep 30. Med Princ Pract. 2009. PMID: 19797927

6

Long-term online hemodiafiltration does not reduce the frequency and severity of acquired cystic kidney disease in hemodialysis patients.

Weng CJ, Chang MY, Chen YC, Tian YC, Fang JT, Yang CW. Weng CJ, et al. Among authors: chang my. Ren Fail. 2009;31(7):555-61. doi: 10.1080/08860220903003412. Ren Fail. 2009. PMID: 19839850

7

Comparison of intracerebral hemorrhage and subarachnoid hemorrhage in patients with autosomal-dominant polycystic kidney disease.

Chang MY, Kuok CM, Chen YC, Ryu SJ, Tian YC, Wu-Chou YH, Tseng FJ, Yang CW. Chang MY, et al. Nephron Clin Pract. 2010;114(2):c158-64. doi: 10.1159/000256568. Epub 2009 Nov 7. Nephron Clin Pract. 2010. PMID: 19907190

8

Inhibition of the P2X7 receptor reduces cystogenesis in PKD.

Chang MY, Lu JK, Tian YC, Chen YC, Hung CC, Huang YH, Chen YH, Wu MS, Yang CW, Cheng YC. Chang MY, et al. J Am Soc Nephrol. 2011 Sep;22(9):1696-706. doi: 10.1681/ASN.2010070728. Epub 2011 Jun 2. J Am Soc Nephrol. 2011. PMID: 21636640 Free PMC article.

9

Outcome scoring systems for short-term prognosis in critically ill cirrhotic patients.

Tu KH, Jenq CC, Tsai MH, Hsu HH, Chang MY, Tian YC, Hung CC, Fang JT, Yang CW, Chen YC. Tu KH, et al. Among authors: chang my. Shock. 2011 Nov;36(5):445-50. doi: 10.1097/SHK.0b013e31822fb7e2. Shock. 2011. PMID: 21841535

10

Endothelin in polycystic kidney disease.

Chang MY, Ong ACM. Chang MY, et al. Contrib Nephrol. 2011;172:200-209. doi: 10.1159/000328701. Epub 2011 Aug 30. Contrib Nephrol. 2011. PMID: 21894000 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results